Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02005445
Recruitment Status : Terminated (Unable to meet recruitment target)
First Posted : December 9, 2013
Results First Posted : July 3, 2019
Last Update Posted : July 3, 2019
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development

Brief Summary:
This is a randomized clinical trial in U.S. Veterans to evaluate the impact of treatment for obstructive sleep apnea (OSA) on the effectiveness of cardiac rehabilitation, including impact on exercise capacity, disability, and quality of life.

Condition or disease Intervention/treatment Phase
Obstructive Sleep Apnea Coronary Heart Disease Device: CPAP Behavioral: HLSE Not Applicable

Detailed Description:
Obstructive sleep apnea (OSA) is a highly prevalent condition in patients with coronary heart disease and is associated with impaired exercise performance, functional limitation and reduced health-related quality of life. The investigators hypothesize that identification and treatment of OSA in patients undergoing cardiac rehabilitation will improve the response to rehabilitation. The proposed study will test this hypothesis using a parallel group, randomized, clinical trial comparing OSA treatment with continuous positive airway pressure (CPAP) to an educational control group in patients undergoing cardiac rehabilitation who screen positive for previously undiagnosed OSA.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 4 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation
Actual Study Start Date : October 1, 2014
Actual Primary Completion Date : December 29, 2017
Actual Study Completion Date : June 29, 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Continuous Positive Airway Pressure (CPAP)
Continuous positive airway pressure
Device: CPAP
Continuous positive airway pressure

Sham Comparator: Healthy Lifestyle and Sleep Education (HLSE)
Healthy living and sleep education
Behavioral: HLSE
Healthy living and sleep education




Primary Outcome Measures :
  1. WHO Disability Assessment Scale 2 Scores [ Time Frame: 12 weeks ]
    Functional status as measured by the World Health Organization Disability Assessment Scale 2.0. Score range 0-48 (higher scores indicate more disability).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Veterans referred for cardiac rehabilitation at the VA Boston Healthcare System.
  • Moderate to severe OSA (AHI >15) on home sleep testing.

Exclusion Criteria:

  • Dangerous levels of sleepiness (Epworth Sleepiness Scale score >16 or a report of falling asleep at the wheel of a car within the past 2 years).
  • Physical limitation precluding exercise testing.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02005445


Locations
Layout table for location information
United States, Massachusetts
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, United States, 02130
Sponsors and Collaborators
VA Office of Research and Development
Investigators
Layout table for investigator information
Principal Investigator: Daniel J Gottlieb, MD MPH VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
  Study Documents (Full-Text)

Documents provided by VA Office of Research and Development:

Layout table for additonal information
Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT02005445     History of Changes
Other Study ID Numbers: F1351-P
First Posted: December 9, 2013    Key Record Dates
Results First Posted: July 3, 2019
Last Update Posted: July 3, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: Yes
Device Product Not Approved or Cleared by U.S. FDA: No
Pediatric Postmarket Surveillance of a Device Product: No
Product Manufactured in and Exported from the U.S.: No

Keywords provided by VA Office of Research and Development:
Obstructive sleep apnea
Coronary heart disease
Cardiac rehabilitation
Cardiopulmonary exercise testing

Additional relevant MeSH terms:
Layout table for MeSH terms
Apnea
Sleep Apnea Syndromes
Heart Diseases
Sleep Apnea, Obstructive
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Cardiovascular Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases